Yüklüyor......

Interactions of L-dopa and amantadine in patients with Parkinsonism

Twenty-seven patients with Parkinson's disease participated in a double-blind crossover trial of L-dopa and amantadine. Each drug was given for six weeks, and six weeks were allowed to elapse between the two periods of treatment. Marked improvement occurred in patients given L-dopa first, where...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cox, B., Danta, G., Schnieden, H., Yuill, G. M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1973
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC494333/
https://ncbi.nlm.nih.gov/pubmed/4714097
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!